ATORVASTATIN Safety Questions, ATORVASTATIN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about ATORVASTATIN. Our extensive database of ATORVASTATIN adverse events and ATORVASTATIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about ATORVASTATIN
ATORVASTATIN Safety Reports
Total ATORVASTATIN reports: 355.ATORVASTATIN FDA safety alerts: 2003 2005 .
Reported deaths: 20 Reported hospitalizations: 141.
Take ATORVASTATIN Side Effects Survey or Share Your ATORVASTATIN Story. Read More Here.
Showing 1-75 of 355 Next >
Physician from GERMANY reported ATORVASTATIN problem on Mar 27, 2007. Male patient was diagnosed with hypercholesterolaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: hearing disability, nasopharyngitis, tinnitus. ATORVASTATIN dosage: DAILY DOSE:20MG-FREQ:DAILY. During the same period patient was treated with JODID, VALSARTAN. Patient recovered.ATORVASTATIN problem was reported by a Physician from GERMANY on Mar 28, 2007. Female patient, 82 years of age, weighting 121.3 lb, was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, thrombosis. ATORVASTATIN dosage: DAILY DOSE:30MG. During the same period patient was treated with METOPROLOL SUCCINATE, QUANTALAN, EUTHYROX, SPIRIVA, MARCUMAR, PLAVIX, CALCIUM, VITAMIN D3. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported ATORVASTATIN problem on Mar 29, 2007. Female patient, 81 years of age, was diagnosed with myocardial ischaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: asthenia, muscle atrophy, myositis. ATORVASTATIN dosage: unknown. During the same period patient was treated with AMLODIPINE, ISOSORBIDE MONONITRATE, ISPAGHULA HUSK, NICORANDIL. Patient recovered.
ATORVASTATIN problem was reported by a Pharmacist from JAPAN on Apr 03, 2007. Male patient, 50 years of age, was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: anxiety, delusion. ATORVASTATIN dosage: unknown. During the same period patient was treated with VALSARTAN. Patient recovered.
Consumer or non-health professional from AUSTRALIA reported ATORVASTATIN problem on Mar 29, 2007. Male patient, weighting 160.9 lb, was diagnosed with coronary artery disease and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: alveolitis fibrosing, chronic obstructive pulmonary disease, hypokalaemia, pulmonary hypertension. ATORVASTATIN dosage: DAILY DOSE:20MG. During the same period patient was treated with PERINDOPRIL ERBUMINE, ASPIRIN, GLICLAZIDE, METFORMIN, AMOXICILLIN, PENICILLIN G, DOXYCYCLINE. Patient was hospitalized. Patient recovered.
ATORVASTATIN problem was reported by a Health Professional from UNITED KINGDOM on Mar 29, 2007. Female patient, 59 years of age, weighting 174.2 lb, was diagnosed with hypercholesterolaemia, hypertension, hypothyroidism and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: anxiety, depressed mood, palpitations. ATORVASTATIN dosage: unknown. During the same period patient was treated with ATENOLOL, LEVOTHYROXINE. Patient recovered.
Health Professional from UNITED KINGDOM reported ATORVASTATIN problem on Apr 03, 2007. Male patient, 58 years of age, weighting 216.9 lb, was diagnosed with rosacea, gout, angina pectoris, hyperlipidaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: hepatotoxicity, liver function test abnormal. ATORVASTATIN dosage: unknown. During the same period patient was treated with MINOCYCLINE, ALLOPURINOL, AMLODIPINE, ATENOLOL, EZETIMIBE, LANSOPRAZOLE. Patient recovered.
ATORVASTATIN problem was reported by a Consumer or non-health professional from INDIA on Apr 05, 2007. Male patient, 17 years of age, weighting 121.3 lb, was diagnosed with lipids abnormal and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ATORVASTATIN dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported ATORVASTATIN problem on Apr 12, 2007. Male patient, weighting 163.1 lb, was diagnosed with hypolipidaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: cryptogenic organising pneumonia. ATORVASTATIN dosage: unknown. During the same period patient was treated with ATENOLOL, BENDROFLUMETHIAZIDE, FELODIPINE, WARFARIN. Patient recovered.
ATORVASTATIN problem was reported by a Physician from GERMANY on Apr 11, 2007. Female patient, 66 years of age, was diagnosed with hypertension, hypercholesterolaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: musculoskeletal pain, neuritis, upper respiratory tract infection. ATORVASTATIN dosage: DAILY DOSE:10MG-FREQ:DAILY. During the same period patient was treated with ATORVASTATIN CALCIUM, ATACAND, DURASOPTIN. Patient recovered.
Health Professional from UNITED KINGDOM reported ATORVASTATIN problem on Apr 16, 2007. Female patient, 74 years of age, was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: haemorrhagic stroke. ATORVASTATIN dosage: unknown. During the same period patient was treated with AMLODIPINE, GLICLAZIDE, METFORMIN, PARACETAMOL, PIOGLITAZONE, SIMVASTATIN. Patient was hospitalized. Patient recovered.
ATORVASTATIN problem was reported by a Physician from GERMANY on Apr 16, 2007. Male patient was diagnosed with prophylaxis and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, muscle disorder. ATORVASTATIN dosage: unknown. During the same period patient was treated with ISCOVER. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ATORVASTATIN problem on Apr 18, 2007. Male patient, weighting 239.0 lb, was diagnosed with hyperlipidaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: amnesia, asthenia, cognitive disorder, depression, disorientation, fatigue, irritability, myopathy, neuropathy peripheral. ATORVASTATIN dosage: unknown. Patient recovered.
ATORVASTATIN problem was reported by a Physician from GERMANY on Apr 17, 2007. Male patient, weighting 165.3 lb, was diagnosed with prophylaxis, blood cholesterol increased and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: central nervous system lymphoma, disturbance in attention, lipids abnormal, memory impairment. ATORVASTATIN dosage: DAILY DOSE:40MG. During the same period patient was treated with ATORVASTATIN CALCIUM, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported ATORVASTATIN problem on Apr 26, 2007. Female patient, 82 years of age, weighting 90.00 lb, was diagnosed with hyperlipidaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: gait disturbance, muscle atrophy, renal failure acute, rhabdomyolysis. ATORVASTATIN dosage: 40 MG DAILY PO. During the same period patient was treated with ASPIRIN, ATENOLOL, COLCHICINE, NIFEDIPINE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
ATORVASTATIN problem was reported by a Physician from GERMANY on Apr 19, 2007. Female patient, 82 years of age, weighting 121.3 lb, was diagnosed with hyperlipidaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, thrombosis. ATORVASTATIN dosage: DAILY DOSE:30MG. During the same period patient was treated with METOPROLOL SUCCINATE, QUANTALAN, EUTHYROX, SPIRIVA, MARCUMAR, PLAVIX, CALCIUM CHLORIDE, VITAMIN D3. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported ATORVASTATIN problem on Apr 20, 2007. Male patient, weighting 176.4 lb, was diagnosed with myocardial ischaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: photosensitivity reaction, sunburn. ATORVASTATIN dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, RABEPRAZOLE. Patient recovered.
ATORVASTATIN problem was reported by a Pharmacist from GERMANY on Apr 23, 2007. Male patient, 64 years of age, was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, aortic aneurysm, diarrhoea. ATORVASTATIN dosage: DAILY DOSE:40MG. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported ATORVASTATIN problem on Apr 24, 2007. Male patient, 45 years of age, was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: coronary artery restenosis. ATORVASTATIN dosage: unknown. During the same period patient was treated with CLOPIDOGREL. Patient was hospitalized. Patient recovered.
ATORVASTATIN problem was reported by a Health Professional from UNITED KINGDOM on Apr 25, 2007. Male patient, 38 years of age, was diagnosed with hyperlipidaemia, hypertension, renal transplant, hepatitis b and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: spermatozoa progressive motility abnormal. ATORVASTATIN dosage: unknown. During the same period patient was treated with DOXAZOSIN MESYLATE, ASPIRIN, ATENOLOL, CELLCEPT, ISONIAZID, NEORAL, LAMIVUDINE, PERINDOPRIL. Patient recovered.
Physician from GERMANY reported ATORVASTATIN problem on Apr 23, 2007. Male patient, weighting 154.3 lb, was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: muscle rupture. ATORVASTATIN dosage: DAILY DOSE:10MG. During the same period patient was treated with ASPIRIN. Patient recovered.
ATORVASTATIN problem was reported by a Health Professional from UNITED KINGDOM on Apr 24, 2007. Male patient, 72 years of age, was diagnosed with blood cholesterol increased, liver transplant and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: anorexia, chromaturia, constipation, faeces discoloured, liver function test abnormal, pruritus, transplant rejection. ATORVASTATIN dosage: unknown. During the same period patient was treated with CYCLOSPORINE, ALLOPURINOL, ACETYLSALICYLIC ACID SRT, CLOPIDOGREL, GOSERELIN, LOSARTAN POSTASSIUM, NICORANDIL, OLMESARTAN MEDOXOMIL. Patient was hospitalized. Patient recovered.
Health Professional from INDIA reported ATORVASTATIN problem on Apr 20, 2007. Male patient, 17 years of age, weighting 121.3 lb, was diagnosed with nephrotic syndrome and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: gait disturbance, rhabdomyolysis. ATORVASTATIN dosage: 10 MG, QD, ORAL. During the same period patient was treated with PREDNISOLONE. Patient recovered.
ATORVASTATIN problem was reported by a Health Professional from UNITED KINGDOM on Apr 26, 2007. Male patient, 64 years of age, was diagnosed with blood cholesterol increased and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, myopathy, renal failure acute. ATORVASTATIN dosage: unknown. During the same period patient was treated with EZETIMIBE, NIFEDIPINE. Patient was hospitalized. Patient recovered.
Health Professional from GERMANY reported ATORVASTATIN problem on Apr 30, 2007. Male patient, weighting 172.0 lb, was diagnosed with hyperlipidaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: asthenia, hepatic necrosis, jaundice, transaminases increased. ATORVASTATIN dosage: DAILY DOSE:20MG. Patient recovered.
ATORVASTATIN problem was reported by a Health Professional from UNITED KINGDOM on May 03, 2007. Female patient, 69 years of age, weighting 143.3 lb, was diagnosed with lipids increased, renal failure chronic, blood pressure, gastric disorder and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: lichen planus. ATORVASTATIN dosage: unknown. During the same period patient was treated with ALFACALCIDOL, ATENOLOL, DOXAZOSIN MESYLATE, FRUSEMIDE, LANSOPRAZOLE, LISINOPRIL. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ATORVASTATIN problem on Apr 30, 2007. Female patient, weighting 158.1 lb, was diagnosed with blood cholesterol increased and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: abasia, chest discomfort, decreased appetite, dyspnoea, flatulence, inflammation, muscle spasms, musculoskeletal discomfort, myalgia. ATORVASTATIN dosage: unknown. During the same period patient was treated with SYNTHROID, VALSARTAN, CLONAZEPAM. Patient was hospitalized. Patient recovered.
ATORVASTATIN problem was reported by a Physician from CANADA on May 02, 2007. Male patient, 56 years of age, was diagnosed with acute coronary syndrome, angiogram, stent placement and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: dizziness, erosive duodenitis, erosive oesophagitis, gastrointestinal haemorrhage, malaise. ATORVASTATIN dosage: unknown. During the same period patient was treated with RAMIPRIL, METOPROLOL SUCCINATE, PLAVIX, ASPIRIN. Patient recovered.
Physician from SWITZERLAND reported ATORVASTATIN problem on May 10, 2007. Male patient, 88 years of age, was diagnosed with essential hypertension, benign prostatic hyperplasia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: orthostatic hypotension, presyncope. ATORVASTATIN dosage: unknown. During the same period patient was treated with ASPIRIN, ADALAT, XATRAL UNO. Patient was hospitalized. Patient recovered.
ATORVASTATIN problem was reported by a Pharmacist from UNITED STATES on May 25, 2007. Male patient, 67 years of age, weighting 229.3 lb, was diagnosed with blood cholesterol and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, chest pain. ATORVASTATIN dosage: 40 MG PO DAILY. During the same period patient was treated with LAMOTRIGINE, METHADONE, NIASPAN ER, TAMSULOSIN, TRAZODONE, GLYCOLAX, TRIAMTERENE, POTASSIUM ACETATE. Patient was hospitalized. Patient recovered.
Physician from SWITZERLAND reported ATORVASTATIN problem on May 21, 2007. Male patient, weighting 191.8 lb, was diagnosed with hyperlipidaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: muscle spasms. ATORVASTATIN dosage: unknown. During the same period patient was treated with INSULIN DETEMIR, NOVORAPID, METFORMIN, PLAVIX. Patient recovered.
ATORVASTATIN problem was reported by a Physician from GERMANY on May 23, 2007. Female patient, weighting 121.3 lb, was diagnosed with hypercholesterolaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: polymyalgia rheumatica. ATORVASTATIN dosage: unknown. During the same period patient was treated with EZETROL, DECORTIN. Patient recovered.
Physician from UNITED KINGDOM reported ATORVASTATIN problem on May 24, 2007. Male patient, 71 years of age, weighting 174.2 lb, was diagnosed with diabetes mellitus insulin-dependent, renal failure chronic, muscle spasms, dyspepsia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: alopecia, anorexia, arthralgia, arthritis, asthenia, back pain, blood glucose fluctuation, fatigue, feeling hot. ATORVASTATIN dosage: unknown. During the same period patient was treated with QUININE SULPHATE, NOVOMIX, INSULATARD, ESOMEPRAZOLE MAGNESIUM, CLOPIDOGREL, EZETIMIBE. Patient recovered.
ATORVASTATIN problem was reported by a Health Professional from UNITED KINGDOM on May 25, 2007. Female patient, 88 years of age, weighting 165.3 lb, was diagnosed with atrial fibrillation, dyspepsia, hypothyroidism and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: disorientation. ATORVASTATIN dosage: unknown. During the same period patient was treated with AMIODARONE, ACETYLSALICYLIC ACID SRT, FRUSEMIDE, LEVOTHYROXINE, WARFARIN. Patient was hospitalized. Patient recovered.
Health Professional from ITALY reported ATORVASTATIN problem on May 31, 2007. Female patient, 61 years of age, was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: hypotonia, syncope. ATORVASTATIN dosage: unknown. Patient was hospitalized. Patient recovered.
ATORVASTATIN problem was reported by a Physician from GERMANY on May 31, 2007. Male patient, weighting 152.1 lb, was diagnosed with lipid metabolism disorder and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: gait disturbance, muscular weakness, myalgia. ATORVASTATIN dosage: unknown. Patient recovered.
Health Professional from UNITED KINGDOM reported ATORVASTATIN problem on May 30, 2007. Male patient, 41 years of age, was diagnosed with hiv infection and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: atrophy. ATORVASTATIN dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE, COMBIVIR, RITONAVIR, ABACAVIR SULPHATE. Patient recovered.
ATORVASTATIN problem was reported by a Physician from GERMANY on June 01, 2007. Female patient, weighting 116.8 lb, was diagnosed with hypercholesterolaemia, breast cancer and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood creatine phosphokinase increased, blood urea increased, myalgia. ATORVASTATIN dosage: unknown. During the same period patient was treated with ARIMIDEX. Patient recovered.
Health Professional from UNITED KINGDOM reported ATORVASTATIN problem on June 07, 2007. Male patient, 44 years of age, was diagnosed with myocardial infarction, coronary artery disease, stent placement and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: pruritus, rash maculo-papular. ATORVASTATIN dosage: unknown. During the same period patient was treated with DIAZEPAM, OMACOR, PLAVIX, ACETYLSALICYLIC ACID SRT, LANSOPRAZOLE, METOPROLOL SUCCINATE. Patient was hospitalized. Patient recovered.
ATORVASTATIN problem was reported by a Health Professional from GERMANY on June 12, 2007. Female patient, weighting 154.3 lb, was diagnosed with hypercholesterolaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, metabolic disorder. ATORVASTATIN dosage: unknown. During the same period patient was treated with EZETIMIBE, LOCOL, BISOPROLOL FUMARATE, THIAMAZOLE, AQUAPHORLET, MARCUMAR. Patient was hospitalized. Patient recovered.
Health Professional from GERMANY reported ATORVASTATIN problem on June 12, 2007. Female patient, 66 years of age, was diagnosed with hypertension, hypercholesterolaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: musculoskeletal pain, neuritis, upper respiratory tract infection. ATORVASTATIN dosage: DAILY DOSE:10MG-FREQ:DAILY. During the same period patient was treated with ATORVASTATIN CALCIUM, ATACAND, DURASOPTIN. Patient recovered.
ATORVASTATIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 12, 2007. Male patient, 53 years of age, weighting 220.5 lb, was diagnosed with blood cholesterol increased and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, multi-organ failure, pancreatitis necrotising. ATORVASTATIN dosage: unknown. During the same period patient was treated with RAMIPRIL. Patient was hospitalized and became disabled. Patient recovered.
Physician from FRANCE reported ATORVASTATIN problem on June 14, 2007. Male patient, weighting 165.3 lb, was diagnosed with hypercholesterolaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, myalgia, paraesthesia. ATORVASTATIN dosage: unknown. During the same period patient was treated with PRAVASTATIN, ASPIRIN, DEROXAT, SPECIAFOLDINE, PLAVIX. Patient recovered.
ATORVASTATIN problem was reported by a Health Professional from UNITED KINGDOM on June 12, 2007. Female patient, 69 years of age, weighting 202.8 lb, was diagnosed with hypercholesterolaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: confusional state. ATORVASTATIN dosage: unknown. During the same period patient was treated with ROSUVASTATIN, ATENOLOL, FELODIPINE, FUROSEMIDE, LEVOTHYROXINE. Patient recovered.
Health Professional from UNITED KINGDOM reported ATORVASTATIN problem on June 18, 2007. Male patient, 53 years of age, weighting 220.5 lb, was diagnosed with blood cholesterol increased and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, multi-organ failure, pancreatitis necrotising. ATORVASTATIN dosage: unknown. During the same period patient was treated with RAMIPRIL. Patient was hospitalized and became disabled. Patient recovered.
ATORVASTATIN problem was reported by a Physician from FRANCE on June 21, 2007. Female patient, 80 years of age, was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: hepatitis. ATORVASTATIN dosage: unknown. Patient died.
Physician from HUNGARY reported ATORVASTATIN problem on June 22, 2006. Male patient, 62 years of age, was diagnosed with hypercholesterolaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: coma hepatic, hepatic cirrhosis. ATORVASTATIN dosage: 20 MG (40 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ASPIRIN, BETALOC, ENALAPRIL MALEATE. Patient was hospitalized. Patient died on 06/16/2006.
ATORVASTATIN problem was reported by a Physician from on June 23, 2006. Male patient, 60 years of age, was diagnosed with hypercholesterolaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, chills, fatigue, gamma-glutamyltransferase increased, hepatic steatosis, influenza like illness, nasopharyngitis. ATORVASTATIN dosage: (10 MG, 1 IN 1 D),. During the same period patient was treated with CLOPIDOGREL. Patient recovered.
Physician from GERMANY reported ATORVASTATIN problem on June 27, 2006. Female patient, 58 years of age, weighting 136.7 lb, was diagnosed with diabetes mellitus, low density lipoprotein increased and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: depression, disturbance in attention, muscle atrophy, muscular weakness. ATORVASTATIN dosage: 10 MG (10 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ATORVASTATIN CALCIUM. Patient recovered.
ATORVASTATIN problem was reported by a Physician from JAPAN on June 28, 2006. Female patient, 53 years of age, was diagnosed with ill-defined disorder and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood cholesterol increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, blood triglycerides increased, goitre, primary hypothyroidism. ATORVASTATIN dosage: unknown. Patient recovered.
Physician from GERMANY reported ATORVASTATIN problem on June 23, 2006. Male patient was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: gamma-glutamyltransferase increased, transaminases increased. ATORVASTATIN dosage: 10 MG (10 MG, 1 IN 1 D), ORAL. During the same period patient was treated with FLUOXETINE. Patient recovered.
ATORVASTATIN problem was reported by a Physician from FRANCE on June 28, 2006. Male patient, 47 years of age, was diagnosed with ill-defined disorder and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased, pancreatic disorder, pancreatitis acute. ATORVASTATIN dosage: 10 MG (10 MG, 1 IN 1 D). Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported ATORVASTATIN problem on July 05, 2006. Male patient, 77 years of age, was diagnosed with ill-defined disorder, chronic obstructive pulmonary disease and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: mesothelioma. ATORVASTATIN dosage: 10 MG (DAILY). During the same period patient was treated with LACTULOSE, SPIRONOLACTONE, TEMAZEPAM, COMBIVENT, DILTIAZEM, SALBUTAMOL, ASPIRIN, BECLOMETHASONE. Patient died on 07/01/2004.
ATORVASTATIN problem was reported by a Health Professional from UNITED KINGDOM on July 03, 2006. Male patient, 79 years of age, weighting 170.9 lb, was diagnosed with myocardial ischaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, haematocrit decreased, haemoglobin decreased, hypotension, renal failure acute, rhabdomyolysis. ATORVASTATIN dosage: 40 MG (40 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ASPIRIN, ATENOLOL, CLOPIDOGREL, DIGOXIN, FLOXACILLIN, FUCIDINE CAP, FUROSEMIDE, ISOSORBIDE. Patient died on 04/23/2006.
Consumer or non-health professional from UNITED STATES reported ATORVASTATIN problem on July 06, 2006. Male patient, 69 years of age, weighting 178.0 lb, was diagnosed with hypercholesterolaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: aortic valve incompetence, electrocardiogram st-t change, lung hyperinflation, mitral valve incompetence, palpitations, pleural effusion, sinus bradycardia, tricuspid valve incompetence, troponin i increased. ATORVASTATIN dosage: 40 MG (40 MG, 1 IN 1 D). During the same period patient was treated with SERTRALINE, ASPIRIN, COMBIVENT. Patient was hospitalized. Patient recovered.
ATORVASTATIN problem was reported by a Physician from UNITED STATES on July 10, 2006. Female patient was diagnosed with stent placement and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: coronary artery dissection, coronary artery restenosis. ATORVASTATIN dosage: unknown. During the same period patient was treated with PLAVIX. Patient recovered.
Physician from FRANCE reported ATORVASTATIN problem on July 10, 2006. Male patient, 81 years of age, was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: facial palsy, haemorrhagic stroke, international normalised ratio increased. ATORVASTATIN dosage: 40 MG (EVERY DAY); ORAL. During the same period patient was treated with PREVISCAN, DUPHALAC, BISOPROLOL FUMARATE, CORDARONE, LASIX, ZOPICLONE, COZAAR. Patient was hospitalized. Patient recovered.
ATORVASTATIN problem was reported by a Physician from FRANCE on July 11, 2006. Male patient, 69 years of age, was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: completed suicide, injury asphyxiation, paranoia. ATORVASTATIN dosage: 40 MG (40 MG, 1 IN 1 D), ORAL. During the same period patient was treated with GLUCOPHAGE, TERCIAN, NEXIUM, ESCITALOPRAM, RAMIPRIL, ASPIRIN, LASIX. Patient died on 05/23/2006.
Pharmacist from UNITED STATES reported ATORVASTATIN problem on July 20, 2006. Male patient, 62 years of age, weighting 242.1 lb, was diagnosed with dyslipidaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. ATORVASTATIN dosage: unknown. During the same period patient was treated with NITROGLYCERIN, FAMOTIDINE, ALBUTEROL SPIROS, ASPIRIN, ALBUTOEROL, QUININE SULPHATE. Patient was hospitalized. Patient recovered.
ATORVASTATIN problem was reported by a Consumer or non-health professional from GERMANY on July 11, 2006. Male patient, 62 years of age, was diagnosed with cerebrovascular accident and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, muscle spasms, muscle twitching, myalgia. ATORVASTATIN dosage: 40 MG (1 IN 1 D), ORAL. During the same period patient was treated with MAGNESIUM, FOLIC ACID, RAMIPRIL, ISCOVER, CARVEDILOL, EZETROL. Patient recovered.
Consumer or non-health professional from BRAZIL reported ATORVASTATIN problem on July 13, 2006. Male patient, 63 years of age, weighting 220.5 lb, was diagnosed with dyslipidaemia, exostosis and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, blood creatine phosphokinase increased, blood glucose abnormal, blood triglycerides increased, bone marrow failure, diarrhoea haemorrhagic, dyspnoea, faeces discoloured, feeling cold. ATORVASTATIN dosage: 10 MG (10 MG, 1 IN 1 D), ORAL. During the same period patient was treated with NSAID, NAPROXEN, DICLOFENAC, CELEBREX, COLCHICINE, ALLOPURINOL, MANIDIPINE. Patient was hospitalized. Patient recovered.
ATORVASTATIN problem was reported by a Consumer or non-health professional from BRAZIL on July 14, 2006. Male patient, 84 years of age, was diagnosed with dyslipidaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: arterial occlusive disease, cardiovascular disorder, hypertension. ATORVASTATIN dosage: 10 MG (10 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ASPIRIN, VALSARTAN. Patient was hospitalized. Patient recovered.
Pharmacist from GERMANY reported ATORVASTATIN problem on July 11, 2006. Female patient, 54 years of age, was diagnosed with type iia hyperlipidaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, muscle fatigue, myalgia. ATORVASTATIN dosage: 10 MG, ORAL. During the same period patient was treated with METOPROLOL SUCCINATE, POTASSIUM, MAGNESIUM, BETA BLOCKING AGENTS, TROMCARDIN. Patient recovered.
ATORVASTATIN problem was reported by a Health Professional from UNITED KINGDOM on July 11, 2006. Male patient, 38 years of age, was diagnosed with hyperlipidaemia, hypertension, renal transplant and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: spermatozoa progressive motility decreased. ATORVASTATIN dosage: unknown. During the same period patient was treated with DOXAZOSIN, ASPIRIN, ATENOLOL, CELLCEPT, CYCLOSPORINE, ISONIAZID, LAMIVUDINE, PERINDOPRIL ERBUMINE. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported ATORVASTATIN problem on July 14, 2006. Male patient, 77 years of age, was diagnosed with ill-defined disorder, chronic obstructive pulmonary disease and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: lung neoplasm malignant, mesothelioma. ATORVASTATIN dosage: 10 MG DAILY. During the same period patient was treated with LACTULOSE, SPIRONOLACTONE, TEMAZEPAM, COMBIVENT, DILTIAZEM, SALBUTAMOL, ASPIRIN, BECLOMETHASONE. Patient died on 07/01/2004.
ATORVASTATIN problem was reported by a Physician from SWITZERLAND on July 18, 2006. Male patient, 60 years of age, weighting 200.6 lb, was diagnosed with hyperlipidaemia, diabetes mellitus non-insulin-dependent and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: bilirubinuria, gamma-glutamyltransferase increased, urobilin urine, venous thrombosis. ATORVASTATIN dosage: 40 MG (40 MG, 1 IN 1 D), ORAL. During the same period patient was treated with AVANDIA, ASPIRIN, ACE INHIBITOR NOS, ATACAND, ASPIRIN CARDIO. Patient recovered.
Consumer or non-health professional from BRAZIL reported ATORVASTATIN problem on July 20, 2006. Male patient was diagnosed with dyslipidaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: angiopathy, back pain, dyspnoea, epistaxis, haemorrhage, hyperaesthesia, myocardial infarction. ATORVASTATIN dosage: 40 MG (20 MG, 2 IN 1 D), ORAL. During the same period patient was treated with CARVEDILOL, MONOCORDIL, CAPTOPRIL, ASPIRIN. Patient was hospitalized. Patient recovered.
ATORVASTATIN problem was reported by a Physician from DENMARK on July 20, 2006. Female patient, 48 years of age, was diagnosed with hypercholesterolaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: liver disorder, renal disorder. ATORVASTATIN dosage: unknown. During the same period patient was treated with PERINDOPRIL ERBUMINE. Patient was hospitalized. Patient recovered.
Physician from AUSTRALIA reported ATORVASTATIN problem on July 21, 2006. Female patient, 58 years of age, was diagnosed with hypercholesterolaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: epilepsy, tongue biting. ATORVASTATIN dosage: 10 MG (10 MG, 1 IN 1 D) ORAL. During the same period patient was treated with METOPROLOL TARTRATE, LISINOPRIL, ISOSORBIDE MONONITRATE, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.
ATORVASTATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2006. Male patient, 71 years of age, weighting 177.9 lb, was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: crohn's disease, dehydration, diarrhoea, renal failure acute, rhabdomyolysis. ATORVASTATIN dosage: unknown. During the same period patient was treated with GEMFIBROZIL. Patient recovered.
Health Professional from UNITED KINGDOM reported ATORVASTATIN problem on June 21, 2006. Female patient, 66 years of age, weighting 132.3 lb, was diagnosed with myocardial ischaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, anxiety, depressed mood, sleep disorder. ATORVASTATIN dosage: 40 MG (40 MG, 1 IN 1 D) ORAL. During the same period patient was treated with CARVEDILOL, GLYCERYL TRINITRATE, LOSEC, PLAVIX. Patient recovered.
ATORVASTATIN problem was reported by a Health Professional from UNITED KINGDOM on July 24, 2006. Male patient, 56 years of age, weighting 224.9 lb, was diagnosed with hyperlipidaemia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: bronchospasm, dyspnoea. ATORVASTATIN dosage: (60 MG), ORAL. During the same period patient was treated with ATENOLOL, ISOSORBIDE. Patient recovered.
Physician from UNITED STATES reported ATORVASTATIN problem on July 27, 2006. Male patient, 80 years of age, was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: band neutrophil percentage increased, blood creatine phosphokinase increased, blood creatinine increased, muscle disorder, muscular weakness, pyrexia, renal failure acute, urinary tract infection. ATORVASTATIN dosage: unknown. During the same period patient was treated with METOPROLOL, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
ATORVASTATIN problem was reported by a Consumer or non-health professional from BRAZIL on July 25, 2006. Male patient, 52 years of age, was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: stent placement. ATORVASTATIN dosage: 20 MG, ORAL. During the same period patient was treated with GLIOTEN, MODURETIC. Patient recovered.
Health Professional from UNITED KINGDOM reported ATORVASTATIN problem on July 04, 2006. Female patient, 73 years of age, was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: hepatic failure, hepatic necrosis, hepatitis acute. ATORVASTATIN dosage: 10 MG, QD. During the same period patient was treated with DEXTROPROPOXYPHENE, AMLODIPINE, ASPIRIN, BENDROFLUAZIDE, DOXAZOSIN, GAVISCON, LANSOPRAZOLE, RAMIPRIL. Patient was hospitalized. Patient died.
Showing 1-75 of 355 Next >
This
drug has an active FDA Safety Alert